New Antibody Targets HIV Glycoprotein at Different Conformations Caltech has discovered a broadly neutralizing antibody (bNAb) that can bind to both partially open and closed conformation of the HIV-1 envelope glycoprotein. Typically bNAbs only target the HIV-1 envelope… Read More
August 2015: The Antibody Update
The biotechnology industry is defined by cutting edge discoveries, breakthrough therapies, and new research methods. ProSci is here to help you keep up. As a major player in Custom Antibody Development, it is our responsibility… Read More